Mechanism of activation and the rewired network: New drug design concepts.

Abstract excerpt

Precision oncology benefits from effective early phase drug discovery decisions. Recently, drugging inactive protein conformations has shown impressive successes, raising the cardinal questions of which targets can profit and what are the principles of the active/inactive protein pharmacology. Cancer driver mutations have been established to mimic the protein activation mechanism. We suggest that the decision...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Design
• Share to Mutation
• Share to Neoplasms